tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
aTyr Pharma says DSMB recommends continuation of study without any modifications
PremiumThe FlyaTyr Pharma says DSMB recommends continuation of study without any modifications
2y ago
aTyr Pharma reports Q1 EPS (23c), consensus (24c)
Premium
The Fly
aTyr Pharma reports Q1 EPS (23c), consensus (24c)
2y ago
3 Best Stocks to Buy Now, 3/18/2024, According to Top Analysts 
Premium
Market News
3 Best Stocks to Buy Now, 3/18/2024, According to Top Analysts 
2y ago
aTyr Pharma announces appointment of Frederick as advisor
PremiumThe FlyaTyr Pharma announces appointment of Frederick as advisor
2y ago
aTyr Pharma’s efzofitimod shows immune function in rheumatoid arthritis
Premium
The Fly
aTyr Pharma’s efzofitimod shows immune function in rheumatoid arthritis
2y ago
aTyr Pharma files $300M mixed securities shelf
Premium
The Fly
aTyr Pharma files $300M mixed securities shelf
2y ago
aTyr Pharma price target raised to $20 from $13 at Piper Sandler
PremiumThe FlyaTyr Pharma price target raised to $20 from $13 at Piper Sandler
3y ago
aTyr Pharma downgraded to Perform at Oppenheimer on few material catalysts
Premium
The Fly
aTyr Pharma downgraded to Perform at Oppenheimer on few material catalysts
3y ago
aTyr Pharma downgraded to Perform from Outperform at Oppenheimer
Premium
The Fly
aTyr Pharma downgraded to Perform from Outperform at Oppenheimer
3y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100